Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...

Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Looking to move up in your current job or change careers? Try a ...

New research is shedding light on surprising ways to reduce chronic inflammation—including suggestions as simple as flossing ...

Marc Dervaes journeyed to Mexico for a psychedelic drug that more military veterans are hoping will relieve their trauma.

Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), ...

Lauren Goodman, a registered nurse at Juliana Clinics in Beverly Hills, says she’s had people traveling from around the US to ...

Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported preliminary, ...